0.1040
-0.0251
(-19.44%)
At close: January 24 at 4:00:01 PM EST
0.0983
-0.01
(-5.48%)
Pre-Market: 6:31:17 AM EST
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.05M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| SEELENBERGER ALEXANDER A. Officer | Purchase at price 0.95 per share. | Direct | 9,968 | Aug 11, 2023 |
| THOMAS TOM C President | Purchase at price 0.95 per share. | Direct | 4,750 | Aug 10, 2023 |
| HAMDY AHMED President | Purchase at price 0.95 - 0.96 per share. | Indirect | 21,161 | Aug 10, 2023 |
| IZUMI RAQUEL E. President | Purchase at price 0.90 - 0.93 per share. | Indirect | 14,934 | Aug 10, 2023 |
| THOMAS TOM C General Counsel | Purchase at price 0.83 per share. | Indirect | 5,810 | Dec 14, 2022 |
| HAMDY AHMED Chief Executive Officer | Purchase at price 0.87 per share. | Indirect | 30,538 | Dec 14, 2022 |
| IZUMI RAQUEL E. President | Purchase at price 0.88 per share. | Indirect | 25,427 | Dec 14, 2022 |
| LOWE CHRISTOPHER P Director | Purchase at price 1.65 per share. | Direct | 49,438 | Aug 25, 2022 |
| IZUMI RAQUEL E. President | Purchase at price 1.41 per share. | Indirect | 56,312 | Jun 27, 2022 |
| HAMDY AHMED Chief Executive Officer | Purchase at price 1.41 per share. | Indirect | 34,137 | Jun 23, 2022 |
| BUSHNELL LAURA I Director | Purchase at price 1.91 per share. | Direct | 28,624 | Jun 9, 2022 |
| HWANG SOOIN Officer | Purchase at price 10.00 per share. | Direct | 30,000 | Dec 23, 2021 |
| THOMAS TOM C General Counsel | Purchase at price 10.23 per share. | Indirect | 10,230 | Dec 22, 2021 |
| HAMDY AHMED Chief Executive Officer | Purchase at price 10.02 per share. | Indirect | 64,650 | Dec 22, 2021 |
| SEELENBERGER ALEXANDER A. Chief Financial Officer | Purchase at price 10.34 per share. | Direct | 24,988 | Dec 22, 2021 |
| BUSHNELL LAURA I Director | Purchase at price 10.48 per share. | Direct | 25,173 | Dec 22, 2021 |
| IZUMI RAQUEL E. President | Purchase at price 11.96 per share. | Indirect | 11,960 | Aug 4, 2021 |
| LOWE CHRISTOPHER P Director | Purchase at price 12.59 - 12.66 per share. | Direct | 126,152 | Jun 30, 2021 |
| BUSHNELL LAURA I Director | Purchase at price 12.94 per share. | Direct | 23,297 | Jun 30, 2021 |
| HWANG SOOIN Officer | Purchase at price 12.66 per share. | Direct | 6,330 | Jun 30, 2021 |
| THOMAS TOM C General Counsel | Purchase at price 12.58 per share. | Indirect | 25,160 | Jun 29, 2021 |
| HAMDY AHMED Chief Executive Officer | Purchase at price 12.77 per share. | Indirect | 99,989 | Jun 29, 2021 |
| MCDONALD ANDREW I Director | Purchase at price 12.38 per share. | Direct | 247,600 | Jun 29, 2021 |
| SEELENBERGER ALEXANDER A. Chief Financial Officer | Purchase at price 12.61 per share. | Direct | 100,260 | Jun 29, 2021 |
| LEE JOHN H. Director | Purchase at price 12.71 per share. | Direct | 10,159 | Jun 29, 2021 |
| HAMDY AHMED Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 23, 2020 |
| DRUKER BRIAN J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 23, 2020 |
| IZUMI RAQUEL E. Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 23, 2020 |
| BYRD JOHN C Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 23, 2020 |
Related Tickers
AEON AEON Biopharma, Inc.
0.1383
+8.05%
CDT Conduit Pharmaceuticals Inc.
4.5200
-9.60%
CNSP CNS Pharmaceuticals, Inc.
0.1058
+10.67%
ADTX Aditxt, Inc.
0.1173
+5.01%
AZTR Azitra, Inc.
0.2679
+6.27%
EYEN Eyenovia, Inc.
0.0571
+5.35%
BLRX BioLineRx Ltd.
0.1093
-5.69%
WINT Windtree Therapeutics, Inc.
0.1792
-11.07%
HEPA Hepion Pharmaceuticals, Inc.
0.1906
-4.70%
ERNA Eterna Therapeutics Inc.
0.5661
-2.40%